33
1 Transfer of expertise on rare metabolic disease in adults: the TEAM-study Karolinska Hospital, Stockholm May 11, 2001

Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

1

Transfer of expertise on rare metabolic disease in adults:

the TEAM-study

Karolinska Hospital, StockholmMay 11, 2001

Page 2: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

2

EU-programmes

Community Action on Rare Diseases1: Information databases2: Training of professionals3: Support of patient groups4: Epidemiologic surveillance

Page 3: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

3

TEAM-study

Transfer of Expertise on rAreMetabolic diseases in adults

Harold W de ValkZaira M BarrientosDept. Internal MedicineUniversity Medical Center Utrecht, The Netherlands

Page 4: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

4

TEAM-study

Essential starting points• Lack of knowledge on a new patient group• Available information is scattered among

experts and not easily found• Available information is not easily

conceptually accesible and quality or scientific foundation of information (very) uncertain

Page 5: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

5

TEAM-study

Potential consequences• Delay in diagnosis• Delay in initiation treatment• Erroneous choice of treatment• Negative influence on prognosis and

quality-of-life

Page 6: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

6

TEAM-study

The birth of the TEAM-study• Choice of the item in the EU-programme (#2)• Elements of a EU-grant proposal

- background & aims and objectives- project mechanism & feasibility of the mechanism- deliverables- subsidiarity- community-wide application- after the project has come to an end….

Page 7: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

7

TEAM-study

Essentials of the TEAM-studyBackground & aims and objectives

“Mission statement”“To provide quality assessment of current knowledgeon aetiology, epidemiology, diagnosis, treatment,complications and prognosis in adult patients with raremetabolic diseases; design, creation and try-out oftrainings for professionals based on an elementaryconsensus after conclusion of quality assessment”

Page 8: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

8

Quality assessment

“Consensus”

Training sessions

Dissemination of quality-assessed expertise

Page 9: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

9

What’s happening in a physician’s mind

Clinical process

Clinical problem-medical history-physical examination

Hypothesis-Knowledge-Experience-Intuition-Luck- ………...Tests

Diagnosis Therapy & Prognosis

Database

Database Database

Page 10: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

10

TEAM-study

Essentials of the TEAM-studyMechanism of the project & feasibilty of mechanism• Formation of groups of diseases• Choice of experts in the field (6)• Recruiting them for the TEAM-approach• Quality assessment mechanism (Cochrane)• Consensus• Design and creation of trainings• Try-out of trainings

Page 11: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

11

TEAM-study

The different expert groupsGroup 1: Amino acids I • Phenylketonuria• Alkaptonuria• Tyrosinaemia

Utrecht, The Netherlands

Page 12: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

12

Example expert-group

Members

Subgroup-coordinator

Phenylketonuria

Members

Subgroup-coordinator

Alkaptonuria

Members

Subgroup-coordinator

Tyrosinaemia

Amino acid disorder IHead-coordinator

Page 13: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

13

TEAM-study

The different expert groupsGroup 2: Amino acids II• Homocystinuria• Maple syrup disease• Urea cycle defects• Hyperornithinemia

Padova, Italy

Page 14: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

14

TEAM-study

The different expert groupsGroup 3: Carbohydrate disorders• Galactosaemia• Glycogen storage diseases• Fructose disorders

London, UK

Page 15: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

15

TEAM-study

The different expert groupsGroup 4: Organic acidurias• Propionic acidemia (PA)• Methylmalonic aciduria (MMA)• Isovalericaciduria (IVA)

Madrid, Spain

Page 16: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

16

TEAM-study

The different expert groupsGroup 5: Fatty acid disorders• LCHAD, MCAD, LCAD, SCAD• CPT• vLCAD• TFP

Lisbon, Portugal

Page 17: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

17

TEAM-study

The different expert groupsGroup 6: Other disorders• ALD• Lysosomal disorders• Peroxisomal disorders

Paris, France

Page 18: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

18

Basic considerations of theTEAM-approach

• Systematic review of current expertise

systematic review of publications• Systematic means:

-adequate and comprehensive search strategy-accountability of inclusion or exclusion-reproducibility of inclusion or exclusion

• Applies to all types of studies

Page 19: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

19

Systematic review (1)

Systematic reviews• Unit of research: publication (abstracts included?)• Definition of a research question • Definition of the search strategy• Accountability of inclusion non-inclusion: selection• Judgment on the merits of publications: appraisal• Transparent presentation of the results: review

Prevention of bias as much as possible

Page 20: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

20

Systematic reviews (2)

The making of a systematic review1: Definition of a research question2: Writing of a specific protocol3: Search strategy including various items4: Selection and appraisal of publications5: Pooling of data if possible and indicated6: Presentation of the data

Page 21: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

21

Systematic reviews (3)

Selection strategy• Selection of publications: In/exclusion criteria

-age-sex-intervention-follow-up duration

• Transparent selection on predesigned form• Entry of all publications in Reference manager by

coordinating center

Page 22: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

22

Systematic reviews (4)

Selection of publications• No restriction in language (Tower of Babel bias)• Unpublished results or abstracts-only research

-publication bias?-quality deficit of unpublished results?-presentation bias

• Blinded selection

Page 23: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

23

Systematic reviews (5)

Appraisal of publications• Internal validity• External validity• Quantitative aspects (data presentation)• Other relevant items encountered

Page 24: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

24

Systematic reviews (6)

Major items in appraisal of relevant publications-Description of the studied population-Diagnostic procedures-Randomization-Study intervention-Assessment-Follow-up-Side-effects

Page 25: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

25

Specific review question

• The specific review question determines search strategy• The better specified the question, the more tailored the

search strategyEXAMPLE:

-frequency of congenital abnormalities in MPKU-follow-up of adults with PKU-is premature dementia a symptom of carriers ofmethylmamlonic aciduria

• More than one question on a specific item is possible

Page 26: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

26

Items to be considered

• Epidemiology of the disease (prevalence)• Causes and genetics• Clinical presentation• Diagnostic procedures• Therapeutic interventions and strategies• Prognosis

Page 27: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

27

StructureSpecific review question

Type of study Search strategy

Selection of studies Appraisal of studies

Results Pooling/synthesis

Discussion & Conclusion

Page 28: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

28

Cochrane initiative

Collective (EU-programme)

Expert group Expert group Expert group Expert group Expert group Expert group

Cochrane analyses Other products

TrainingsConsensus

Other initiatives

Page 29: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

29

TEAM-study

Essentials of the TEAM-studyDeliverables• Trainings on rare metabolic diseases in adults based

on quality-assessed expertise and based on subsequent elementary consensus

• Trainings for professionals to provide dissemination of new and applicable knowledge

• Accessible knowledge in a database; electronic and non-electroninc dissemination

• Trainings in different languages and for other professionals

Page 30: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

30

TEAM-study

Essentials of the TEAM-studySubsidiarity• Participation of and input from different centers and

countries of the EU

Page 31: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

31

TEAM-study

Essentials of the TEAM-studyCommunity-wide application• Accessible information database by Internet• Accessible database by non-electronic means• Trainings in different countries and different

languages, accomodating differences in culture

Page 32: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

32

TEAM-study

Essentials of the TEAM-studyAfter the project has come to an end• Continuation of the trainings (fees for particpation,

other sources)• Updating of the trainings • TEAM-study as initiator of collaborative networks

Page 33: Transfer of expertise on rare metabolic disease in adults ... · • Phenylketonuria • Alkaptonuria • Tyrosinaemia Utrecht, The Netherlands. 12 Example expert-group Members Subgroup-coordinator

This report was produced by a contractor for Health & Consumer Protection Directorate General and represents the views of the contractor or author. These views have not been adopted or in any way approved by theCommission and do not necessarily represent the view of the Commission or the Directorate General for Health and Consumer Protection. The European Commission does not guarantee the accuracy of the dataincluded in this study, nor does it accept responsibility for any use made thereof.